300171.SZ
东富龙
SZSE · Healthcare · C 制造业 · CN
CNY 13.77
−4.57%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 5.2B | 5.2B | 5.0B | 5.6B | 5.5B |
| Cost of Revenue | 3.6B | 3.7B | 3.5B | 3.7B | 3.3B |
| Gross Profit | 1.6B | 1.5B | 1.5B | 2.0B | 2.1B |
| Operating Expenses | |||||
| R&D Expense | 329.1M | 337.7M | 346.3M | 379.5M | 332.8M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 610.2M | 601.3M | 553.3M | 553.4M | 471.3M |
| Selling & Marketing Expense | 290.1M | 289.0M | 286.7M | 321.6M | 258.8M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 1.3B | 1.3B | 1.2B | 1.3B | 1.0B |
| Cost and Expenses | 4.9B | 5.0B | 4.8B | 4.9B | 4.4B |
| Operating Income (EBIT) | 280.3M | 266.1M | 215.7M | 702.8M | 999.2M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 281.1M | 264.2M | 227.1M | 708.8M | 1.0B |
| Income Tax Expense | 63.1M | 52.3M | 18.8M | 62.3M | 99.4M |
| Bottom Line | |||||
| Net Income | 207.8M | 200.4M | 194.1M | 600.2M | 846.6M |
| Earnings from Cont. Ops | 218.0M | 211.9M | 208.3M | 646.5M | 903.0M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 207.8M | 200.4M | 194.1M | 600.2M | 846.6M |
| Per Share | |||||
| Basic EPS | CN¥0.27 | CN¥0.26 | CN¥0.26 | CN¥0.79 | CN¥1.34 |
| Diluted EPS | CN¥0.27 | CN¥0.26 | CN¥0.26 | CN¥0.79 | CN¥1.33 |
| Revenue Per Share | CN¥6.85 | CN¥6.79 | CN¥6.71 | CN¥7.43 | CN¥8.66 |
| Shares | |||||
| Basic Shares Outstanding | 760.1M | 770.7M | 746.5M | 759.8M | 631.8M |
| Diluted Shares Outstanding | 760.1M | 770.7M | 746.5M | 759.8M | 631.8M |
| Profitability Metrics | |||||
| EBITDA | — | 428.0M | 338.7M | 797.4M | 1.1B |
| D&A | — | 161.9M | 123.0M | 94.6M | 68.6M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026